Literature DB >> 20156333

Estrogen receptor action in three dimensions - looping the loop.

Vasiliki Theodorou1, Jason S Carroll.   

Abstract

Due to advances in genomic technologies, our understanding of estrogen receptor (ER)-mediated transcription in breast cancer cells has evolved significantly in recent years. Genome-wide mapping experiments revealed thousands of ER-binding events, but linking them to the target genes has been an ongoing struggle. A recent paper describes a new technique, called ChIA-PET (chromatin interaction analysis using paired-end tag sequencing), that can directly address these questions. ChIA-PET is an unbiased approach for simultaneously identifying all genome-wide binding events of a transcription factor and those involved in long-range chromatin loops.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20156333      PMCID: PMC2880425          DOI: 10.1186/bcr2470

Source DB:  PubMed          Journal:  Breast Cancer Res        ISSN: 1465-5411            Impact factor:   6.466


Background

Estrogen receptor (ER) has been one of the most intensively studied transcription factors, primarily due to its importance in breast cancer. Much effort has been invested in identifying the target genes of ER, mainly by expression arrays in breast cancer cell lines and in human tumour samples [1,2]. In the past few years, the evolution of genomic technologies has permitted mapping of ER-binding events in an unbiased manner [3,4]. This involves combining chromatin immunoprecipitation with microarrays or high-throughput sequencing in order to identify ER contact points within the genome. These genome-wide experiments revealed a number of surprising features about ER biology, the most unexpected one being that ER regulates transcription mostly from distal enhancers. This finding raised the subsequent question: which of the thousands of ER-binding events are the functional ones that regulate expression of the few hundred ER target genes? Fullwood and colleagues [5] have now established a method for addressing this question, allowing researchers to assign ER-binding events to transcriptional hubs and target genes.

The article

Researchers at the Genome Institute of Singapore have developed a technique called ChIA-PET (chromatin interaction analysis using paired-end tag sequencing) [5], which couples chromosome conformation capture [6], a method for identifying interacting chromatin regions, with high-throughput sequencing. This permits the global identification of chromatin loops formed at a specific time point. The authors used a well-established system whereby MCF-7 breast cancer cells are cultured in hormone-deprived media and subsequently treated with estrogen for a short time period, resulting in synchronisation of transcriptional events [7]. Using this system, the authors could capture the high-confidence chromatin interactions that form during the first wave of estrogen-ER-mediated transcription. These interactions were extensively validated, supporting their conclusions. The implications of this investigation are profound. It is revealed that chromatin interactions can occur in clusters of contact points and that the actual anchor points, in a linear two-dimensional representation, can be found separated by hundreds of kilobases and in some cases megabases. Contrary to previous suggestions [8], inter-chromosomal interactions do not appear to be a common or experimentally verifiable phenomenon. This suggests that ER-binding events regulate genes within mostly a spatially confined environment, which in many cases involves the folding of multiple regulatory regions into one transcriptional hub. In summary, the authors find 689 ER-associated chromatin interaction complexes made up of duplexes and more complex interactions. These tend to involve the stronger ER-binding events, which are biased toward specific histone marks and other transcriptional regulators important for ER function, such as FoxA1 [9]. By combining the ChIA-PET data with gene expression data, they could discover individual transcriptional hubs and the target genes localised in the vicinity.

The viewpoint

Until now, researchers have been linking enhancers and cis-regulatory elements with the target genes one at a time [10,11]. ChIA-PET circumvents this limitation and can identify all active loops at a given time point, allowing us to redefine the functional ER-binding events. While this constitutes the first snapshot of ER-mediated chromatin loops, it is a quantum leap in our understanding of transcription dynamics. However, this pioneering work leads to a series of new questions. The authors associate the DNA loops that they captured at 45 minutes of estrogen treatment with a time course expression profile of cells treated with estrogen from 0 to 48 hours of treatment. A challenging concept that needs further testing is whether the chromatin loops (captured at 45 minutes) are stable over time or whether they change, leading to the formation of new loops at later time points to regulate transcription of the 'late' target genes. Moreover, what is the role of co-operating transcription factors in loop formation? Also, since many of the ER functional binding events do not directly involve promoter regions, one can speculate that some DNA loops might circum vent the need for a transcription factor to be present at the promoter by concentrating the transcription machinery in the three-dimensional hubs. Furthermore, this technology can be used to explore ER chromatin loops and transcriptional hubs in different breast cancer cell lines and treatment conditions. The identification of transcriptionally active binding events in the different contexts will illuminate the factors that dictate differential binding and transcriptional activity. However, the major limitations of the ChIA-PET technology are the complex technical aspects of the procedure, the heavy bioinformatics demand and the requirement for high-throughput sequencers. Nevertheless, these genomic tools are becoming more readily available, and as such, ChIA-PET will prove to be a powerful tool for delineating mechanisms of transcription in a spatial and temporal manner, applicable to any transcription factor of interest.

Abbreviations

ChIA-PET: chromatin interaction analysis using paired-end tag sequencing; ER: estrogen receptor.

Competing interests

The authors declare that they have no competing interests.
  11 in total

1.  Genome-wide analysis of estrogen receptor binding sites.

Authors:  Jason S Carroll; Clifford A Meyer; Jun Song; Wei Li; Timothy R Geistlinger; Jérôme Eeckhoute; Alexander S Brodsky; Erika Krasnickas Keeton; Kirsten C Fertuck; Giles F Hall; Qianben Wang; Stefan Bekiranov; Victor Sementchenko; Edward A Fox; Pamela A Silver; Thomas R Gingeras; X Shirley Liu; Myles Brown
Journal:  Nat Genet       Date:  2006-10-01       Impact factor: 38.330

2.  FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription.

Authors:  Mathieu Lupien; Jérôme Eeckhoute; Clifford A Meyer; Qianben Wang; Yong Zhang; Wei Li; Jason S Carroll; X Shirley Liu; Myles Brown
Journal:  Cell       Date:  2008-03-21       Impact factor: 41.582

3.  Enhancing nuclear receptor-induced transcription requires nuclear motor and LSD1-dependent gene networking in interchromatin granules.

Authors:  Qidong Hu; Young-Soo Kwon; Esperanza Nunez; Maria Dafne Cardamone; Kasey R Hutt; Kenneth A Ohgi; Ivan Garcia-Bassets; David W Rose; Christopher K Glass; Michael G Rosenfeld; Xiang-Dong Fu
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-03       Impact factor: 11.205

4.  Regulation of estrogen receptor-mediated long range transcription via evolutionarily conserved distal response elements.

Authors:  You Fu Pan; K D Senali Abayratna Wansa; Mei Hui Liu; Bing Zhao; Shu Zhen Hong; Peck Yean Tan; Kar Sian Lim; Guillaume Bourque; Edison T Liu; Edwin Cheung
Journal:  J Biol Chem       Date:  2008-08-25       Impact factor: 5.157

5.  Capturing chromosome conformation.

Authors:  Job Dekker; Karsten Rippe; Martijn Dekker; Nancy Kleckner
Journal:  Science       Date:  2002-02-15       Impact factor: 47.728

6.  Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription.

Authors:  Y Shang; X Hu; J DiRenzo; M A Lazar; M Brown
Journal:  Cell       Date:  2000-12-08       Impact factor: 41.582

7.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

8.  A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.

Authors:  Richard M Neve; Koei Chin; Jane Fridlyand; Jennifer Yeh; Frederick L Baehner; Tea Fevr; Laura Clark; Nora Bayani; Jean-Philippe Coppe; Frances Tong; Terry Speed; Paul T Spellman; Sandy DeVries; Anna Lapuk; Nick J Wang; Wen-Lin Kuo; Jackie L Stilwell; Daniel Pinkel; Donna G Albertson; Frederic M Waldman; Frank McCormick; Robert B Dickson; Michael D Johnson; Marc Lippman; Stephen Ethier; Adi Gazdar; Joe W Gray
Journal:  Cancer Cell       Date:  2006-12       Impact factor: 31.743

9.  Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer.

Authors:  Daniel H Barnett; Shubin Sheng; Tze Howe Charn; Abdul Waheed; William S Sly; Chin-Yo Lin; Edison T Liu; Benita S Katzenellenbogen
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

10.  An oestrogen-receptor-alpha-bound human chromatin interactome.

Authors:  Melissa J Fullwood; Mei Hui Liu; You Fu Pan; Jun Liu; Han Xu; Yusoff Bin Mohamed; Yuriy L Orlov; Stoyan Velkov; Andrea Ho; Poh Huay Mei; Elaine G Y Chew; Phillips Yao Hui Huang; Willem-Jan Welboren; Yuyuan Han; Hong Sain Ooi; Pramila N Ariyaratne; Vinsensius B Vega; Yanquan Luo; Peck Yean Tan; Pei Ye Choy; K D Senali Abayratna Wansa; Bing Zhao; Kar Sian Lim; Shi Chi Leow; Jit Sin Yow; Roy Joseph; Haixia Li; Kartiki V Desai; Jane S Thomsen; Yew Kok Lee; R Krishna Murthy Karuturi; Thoreau Herve; Guillaume Bourque; Hendrik G Stunnenberg; Xiaoan Ruan; Valere Cacheux-Rataboul; Wing-Kin Sung; Edison T Liu; Chia-Lin Wei; Edwin Cheung; Yijun Ruan
Journal:  Nature       Date:  2009-11-05       Impact factor: 49.962

View more
  3 in total

1.  Bisphenol-A induces expression of HOXC6, an estrogen-regulated homeobox-containing gene associated with breast cancer.

Authors:  Imran Hussain; Arunoday Bhan; Khairul I Ansari; Paromita Deb; Samara A M Bobzean; Linda I Perrotti; Subhrangsu S Mandal
Journal:  Biochim Biophys Acta       Date:  2015-02-25

2.  Computational methodology for ChIP-seq analysis.

Authors:  Hyunjin Shin; Tao Liu; Xikun Duan; Yong Zhang; X Shirley Liu
Journal:  Quant Biol       Date:  2013-03-01

3.  A rapid, extensive, and transient transcriptional response to estrogen signaling in breast cancer cells.

Authors:  Nasun Hah; Charles G Danko; Leighton Core; Joshua J Waterfall; Adam Siepel; John T Lis; W Lee Kraus
Journal:  Cell       Date:  2011-05-05       Impact factor: 41.582

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.